Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.

Image source: Getty Images

Breville Group Ltd (ASX: BRG)

According to a note out of Macquarie, its analysts have retained their outperform rating on this appliance manufacturer's shares with a trimmed price target of $37.10. Macquarie has been looking at industry data and believes it is favourable for Breville and suggests that it could be outperforming peers. The broker highlights that this is being driven by growth from its coffee business, as well as new products and new markets. Overall, Macquarie believes this leaves Breville well-placed for annual growth of 10%+ through to FY 2028. The Breville share price ended the week at $26.28.

Cochlear Ltd (ASX: COH)

A note out of UBS reveals that its analysts have retained their buy rating and $302.00 price target on this hearing solutions company's shares. UBS believes that recent share price weakness has created an attractive buying opportunity for investors. This is especially the case given how the broker believes Cochlear's new next-generation cochlear implant platform, Nexa, will underpin a strong earnings recovery. The broker believes that with limited competition, Cochlear is well-placed to win market share. And while there are concerns over gene therapies, UBS doesn't believe this is something that will impact its near term performance. The Cochlear share price was fetching $170.23 at Friday's close.

Liontown Ltd (ASX: LTR)

Another note out of UBS reveals that its analysts have retained their buy rating and $2.20 price target on this lithium miner's shares. UBS is feeling positive about lithium and believes now could be a good time for investors to consider a position in the industry. This is because UBS sees potential for another upcycle for lithium prices. It suspects that surging oil prices and supply disruptions caused by the war in the Middle East could be good news for lithium. It feels that the impact this is having on the fuel market could lead to increased demand for electric vehicles and lithium for batteries. In fact, the broker sees potential for the spodumene price to reach US$4,000 per tonne by the end of the year. The Liontown share price ended the week at $1.76.

Motley Fool contributor James Mickleboro has positions in Cochlear. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A businesswoman on the phone is shocked as she looks at her watch, she's running out of time.
Broker Notes

Is this ASX 200 share a sell after announcing a $30-40 million EBITA hit?

Morgans has lowered its outlook on Worley shares.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Should you buy BHP shares ahead of the miner's production update?

BHP shares could see some big moves after the miner reports its March production results this week.

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Broker Notes

Buy, hold, or sell? Coles, Wesfarmers, BHP shares

ASX 200 shares are in the red as the global oil shock continues to concern investors.

Read more »

Health professional working on his laptop.
Broker Notes

Are Orthocell shares a buy after crashing 7% yesterday?

These healthcare shares could be on discount right now.

Read more »

a happy man eats pizza in his kitchen with a long string of cheese between the pizza slice in his hand and in his mouth.
Broker Notes

Buy, hold, sell: Collins Foods, Domino's, and Guzman Y Gomez shares

Bell Potter has given its verdict on these popular shares this morning.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Why WiseTech shares could rise 70%

Bell Potter is urging investors to buy this tech stock before it rebounds.

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Broker Notes

Why this surging ASX All Ords stock is forecast to rocket another 142%

A leading broker expects this ASX gold stock could more than double investors’ money in the year ahead.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Brokers name 2 skyrocketing ASX energy shares to buy today

Top brokers forecast further strong outperformance from these two surging ASX energy stocks. But why?

Read more »